RxDoctor Payments Data

Jessica Sutherland, MD

Interventional Cardiology · Exeter, NHNPI 1194909978

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,779 of the $2,220 with a category attached, or 80.1%. 9 manufacturers reported payments, led by Abbott at 52.0% of the total. 2025 is the largest year on record at $1,212, 3.5 times the $345 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in NH, where the typical reported total is $5,309.

$2,220in general payments, 2019–2025

Across 33 payments — averaging $67.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Medtronic$380
  • Edwards Lifesciences$283
  • Elutia, Inc.$148
  • Livanova USA, Inc.$93
  • Cvrx, Inc.$69
  • plus $93 from 3 others

What the payments were for

  • Travel & lodging$44120%
  • Food & beverage$1,77980%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,220 in reported general payments places this provider in the 20th percentile of 26 interventional cardiology providers in New Hampshire.

See all interventional cardiology providers in New Hampshire

Medicare billing

Part B allowed, 2024
$121,426
Medicare patients
906
Services billed
2,270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban172$201,330
XareltoRivaroxaban85$99,036
EntrestoSacubitril/Valsartan33$28,611
BrilintaTicagrelor44$20,240
Metoprolol Succinate358$4,456
Rosuvastatin Calcium201$3,066
Atorvastatin Calcium357$2,920
Ezetimibe59$2,508
Digoxin68$2,317
Diltiazem 24hr Er (Cd)Diltiazem Hcl58$1,690
ClopidogrelClopidogrel Bisulfate112$1,383
Warfarin Sodium75$1,141
Flecainide Acetate24$1,042
Nebivolol Hcl16$1,002
Metoprolol Tartrate184$952

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Exeter

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →